ACTIVE

LOMA PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
115,7 k €
-24,7 %over 1 year
Gross margin
420,9 k €
-16,8 %over 1 year
Equity
359,5 k €
+9,3 %over 1 year
Workforce
3,9 ETP
+5,4 %over 1 year

Identity

Source · BCE/KBO

LOMA PHARMA is a Private limited company incorporated in 2003. Its registered office is in Izegem. It employs on average 3,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0862.409.677
Incorporation
26/12/2003
Legal form
Private limited company
Registered office
Meensesteenweg 82
8870 Izegem · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
3,9 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin420,9 k €505,9 k €324,7 k €338,6 k €233,2 k €
EBITDA216,3 k €281,6 k €159,5 k €191,6 k €101,1 k €
Operating result185,5 k €241,5 k €121,7 k €155,1 k €65 k €
Net result115,7 k €153,7 k €62,2 k €89,5 k €14,9 k €
Balance sheet
Equity359,5 k €328,8 k €242,7 k €220,5 k €191 k €
Total assets1,2 M €1,2 M €1,1 M €1,1 M €1 M €
Cash172,8 k €203,4 k €125,5 k €128,2 k €92 k €
Debts786,5 k €866,7 k €851,1 k €829,1 k €810,9 k €
Other
Workforce3,9 ETP3,7 ETP3,6 ETP3,6 ETP3,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 9 ended

Active mandates

NEWHOUSE PHARMACEUTICALS

Director · since 01 mars 2018 · 0687.802.947

Represented by Thomas Vannieuwenhuyse

Active

Ended mandates

NEWHOUSE PHARMACEUTICALS

Director · since 01 mars 2018 · 0687.802.947

Represented by Thomas VANNIEUWENHUYSE

Ended
NEWHOUSE PHARMACEUTICALS

Manager · since 01 mars 2018 · 0687.802.947

Represented by Thomas VANNIEUWENHUYSE

Ended
bvba BVBA CAVANCO

Manager · since 01 janvier 2004

Ended
bvba CAVANCO

Manager · since 01 janvier 2004

Ended

Other companies at this address

Meensesteenweg 82 8870 Izegem
CompanyCBE no.
NEWHOUSE PHARMACEUTICALS● Active
0687.802.947

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year31/12/202531/12/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months15 months12 months12 months12 months12 months
Filing date21/08/202613/08/202518/04/202425/04/202326/04/202222/04/2021
General meeting30/06/202630/06/202502/03/202427/03/202331/03/202231/03/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202621/08/2026DutchPDF
Abridged model31/12/202430/06/202513/08/2025DutchPDF
Abridged model30/09/202302/03/202418/04/2024DutchPDF
Abridged model30/09/202227/03/202325/04/2023DutchPDF
Abridged model30/09/202131/03/202226/04/2022DutchPDF
Abridged model30/09/202031/03/202122/04/2021DutchPDF
Abridged model30/09/201907/03/202029/04/2020DutchPDF
Abridged model30/09/201831/03/201929/04/2019DutchPDF
Abridged model30/09/201703/02/201802/03/2018DutchPDF
Abridged model30/09/201604/03/201724/03/2017DutchPDF
Abridged model30/09/201505/03/201614/03/2016DutchPDF
Abridged model30/09/201431/12/201409/03/2015DutchPDF
Abridged model30/09/201301/03/201425/03/2014DutchPDF
Abridged model30/09/201202/03/201322/03/2013DutchPDF
Abridged model30/09/201131/03/201227/04/2012DutchPDF
Abridged model30/09/201005/03/201103/05/2011DutchPDF
Abridged model30/09/200906/03/201018/05/2010DutchPDF
Abridged model30/09/200807/03/200926/05/2009DutchPDF
Abridged modelCorrection30/09/200701/03/200803/06/2008DutchPDF
Abridged model30/09/200701/03/200829/04/2008DutchPDF
Abridged model30/09/200603/03/200730/03/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 9 ended

Active mandates

NEWHOUSE PHARMACEUTICALS

Director · since 01 mars 2018 · 0687.802.947

Represented by Thomas Vannieuwenhuyse

Active

Ended mandates

NEWHOUSE PHARMACEUTICALS

Director · since 01 mars 2018 · 0687.802.947

Represented by Thomas VANNIEUWENHUYSE

Ended
NEWHOUSE PHARMACEUTICALS

Manager · since 01 mars 2018 · 0687.802.947

Represented by Thomas VANNIEUWENHUYSE

Ended
bvba BVBA CAVANCO

Manager · since 01 janvier 2004

Ended
bvba CAVANCO

Manager · since 01 janvier 2004

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates29/05/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates04/04/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/09/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other08/01/2004
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025115,7 k €↓
  2. 2024
    Annual accounts 2024153,7 k €↑
  3. 2023
    Annual accounts 202362,2 k €↓
  4. 2022
    Annual accounts 202289,5 k €↑
  5. 2021
    Annual accounts 202114,9 k €↓
  6. 2020
    Annual accounts 202077,1 k €↑
  7. 2019
    Annual accounts 201946,9 k €↓
  8. 2018
    Annual accounts 201864,2 k €↓
  9. 2017
    Annual accounts 2017100,2 k €↑
  10. 2016
    Annual accounts 201696,8 k €↓
  11. 2015
    Annual accounts 2015107,3 k €↑
  12. 2014
    Annual accounts 201433,5 k €↓
  13. 2013
    Annual accounts 201339 k €↓
  14. 2012
    Annual accounts 201242,1 k €↑
  15. 2010
    Annual accounts 2010-5 k €↓
  16. 2009
    Annual accounts 200927,6 k €↑
  17. 2008
    Annual accounts 20083,8 k €↓
  18. 2007
    Annual accounts 200732,7 k €
  19. 26/12/2003
    IncorporationPrivate limited company